You are here: Home / Staff Directory / Staff Page

Prof Madeleine Trudy King PHD

Position: Cancer Australia Chair in Cancer Quality of Life and Director of the Quality of Life Office

Office: Room 148, Transient Building (F12),
The University of Sydney, NSW 2006
Phone: (612) 9036 6114
Fax: (612) 9036 5292
Email:

Postal Address:
Quality of Life Office
Psycho-oncology Co-operative Research Group (PoCoG)
School of Psychology, Room 148, Transient Building (F12),
University of Sydney NSW 2006


 
Psycho-oncology Co-operative Research Group (PoCoG)

Qualifications

2002

Doctor of Philosophy
Centre for Clinical Epidemiology and Biostatistics (CCEB),
University of Newcastle, NSW, Australia.

Topic: Methods for Interpreting and Comparing Measures of Quality of Life
Supervisor: Annette Dobson

1994

Graduate Diploma in Medical Statistics
Newcastle University, NSW, Australia

_

Diploma in Statistics
University of New England ; Prize for Mathematical Statistics II 1989
(withdrew to take up studies in Medical Statistics at the University of Newcastle)

1984

Bachelor of Science with First Class Honours
University of Sydney, NSW, Australia.

Back to Table of Contents

Previous Appointments

EMPLOYMENT RECORD
July 2008 - ongoing Cancer Australia Chair in Cancer Quality of Life Director,
Quality of Life Office ,
Psycho-oncology Co-operative Research Group (PoCoG)

Professor,
School of Psychology, University of Sydney 
Jan 2008 - June 2008 Associate Professor, Health Services Research
Centre for Health Economics Research and Evaluation (CHERE)
University of Technology, Sydney (UTS), NSW, Australia.
July 2004 - Dec 2007 Senior Lecturer, Health Services Research
CHERE, UTS, NSW, Australia
Feb 2002 - June 2004 Lecturer, Health Services Research
CHERE, UTS, NSW, Australia.
Jan 1992 - Jan 2002 Biostatistician, CHERE
Central Sydney Area Health Service (1997 - 2001)
Westmead Hospital (1992-1996).
Mar-Dec 1991 Biostatistician, Department of Community Medicine
Westmead Hospital, University of Sydney, NSW, Australia.
Jan 1990 - Mar 1991 Project Manager, Discipline of Medicine
University of Newcastle, Newcastle, NSW, Australia.
Mar 1985 - Jan 1990 Biometricians' Assistant, Fisheries Research Institute
NSW Dept of Agriculture and Fisheries
Dec 1984 - Mar 1985 Technical Officer, Scientific Services
NSW National Parks and Wildlife Services
Feb-Dec 1984 Technical Officer, Wood Technology and Forest Research Division
NSW State Forestry Commission

HONORARY APPOINTMENTS

June 2011 - ongoing

Honorary Associate, Sydney Medical School, University of Sydney

June 2008 - ongoing

Visiting Professor, Health Services Research ,
Centre for Health Economics Research and Evaluation (CHERE) University of Technology, Sydney (UTS), NSW, Australia.

2007

Visiting Scholar ,
Psycho-Oncology Co-operative Research Group

2005 – 2008

Honorary Senior Lecturer,
Faculty of Medicine, School of Public Health, University of Sydney, NSW, Australia.

2003 – 2004

Honorary Lecturer, Faculty of Medicine, School of Public Health
University of Sydney, NSW, Australia.


Back to Table of Contents

Publications

BOOK CHAPTERS

Osoba D and King MT. Interpreting QOL in individuals and groups: meaningful differences. In Peter Fayers & Ron Hays (Eds) Assessing quality of life in clinical trials: Methods and practice 2nd ed., pp. 243 - 257, Oxford University Press, 2005.

ORIGINAL RESEARCH PAPERS IN PEER-REVIEWED JOURNALS –IN PRESS
  • Butow PN, Aldridge LJ, Bell ML, Sze ML, Eisenbruch M, Jefford M, Schofield P, Girgis A, King MT, Duggal-Beri P, McGrane J, Goldstein D. Inferior health-related quality of life and psychological well-being in immigrant cancer survivors: A population-based study. European Journal of Cancer. In press, accepted 18/01/2013.
  • Petersen MA, Aaronson NK, Arraras JI, Chie W, Conroy T, Costantini A, Giesinger JM, Holzner B, King MT, Singer S, Velikova G, Verdonck-de Leeuw IM, Young T& Groenvold T, on behalf of the EORTC Quality of Life Group. The EORTC computer-adaptive tests (CATs) measuring physical functioning and fatigue exhibited high levels of measurement precision and efficiency. Journal of Clinical Epidemiology. In press, accepted 12/09/2012.

ORIGINAL RESEARCH PAPERS IN PEER-REVIEWED JOURNALS - PUBLISHED

  • Smith AB, King MT, Butow P, Olver I. A comparison of data quality and practicality of online versus postal questionnaires in a sample of testicular cancer survivors. Psycho-Oncology, 2013: 22(1), 233-237. DOI 10.1002/pon
  • Bell M, Olivier J, King MT. Scientific rigour in psycho-oncology trials: why and how to avoid common statistical errors. Psycho-Oncology. Published online 07/02/2012, DOI 10.1002/pon.3046.
  • Ediebah DE, Coens C, Maringwa JT, Quinten C, Zikos E, Ringash J, King M, Gotay C, Flechtner HH, Schmucker von Koch JJ, Weis J, Smit EF, Köhne CH, Bottomley A & on behalf of the Gastro-Intestinal Tract Cancer Cooperative Group, Lung Cancer Cooperative Group, Quality of Life Department and Patient Reported Outcome and Behavioural Evidence (PROBE). Effect of completion-time windows in the analysis of health-related quality-of-life outcomes in cancer patients. Annals of Oncology, 2013, 24(1):231-237. DOI: 10.1093/annonc/mds220.
  • Alison JA, Kenny P, King MT, McKinley S, Aitken LM, Leslie GD, Elliott D. Repeatability of six-minute walk test and relation to physical function in survivors of a critical illness. Physical Therapy Journal. 2012: 92(12),1556-63.
  • Quinten C, Maringwa J, Gotay CC, Martinelli F, Coens C, Reeve BB, Flechtner H, Greimel E, King M, Osoba D, Cleeland C, Ringash J, Schmucker-Von Koch J, Taphoorn MJ, Weis J, Bottomley A. Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. Journal of the National Cancer Institute, 2011: 103(24):1851-8. doi: 10.1093/jnci/djr485.
  • Brundage M, Blazeby J, Revicki D, Bass B, de Vet H, Duffy H, Efficace F, King M, Lam CKL, Moher D, Scott J, Sloan J, Snyder C, Yount S, Calvert M. Patient Reported Outcomes in Randomized Clinical Trials: Development of ISOQOL Reporting Standards. Quality of Life Research, 2012, DOI 10.1007/s11136-012-0252-1.
  • Longman T, Turner RM, King MT, McCaffery KJ. The Effects of Communicating Uncertainty in Quantitative Health Risk Estimates. Patient Education and Counselling. 2012: 89(2), 252-259. DOI 10.1016/j.pec.2012.07.010
  • Goodall S, King MT, Ewing J, Smith N, Kenny P. Preferences for support services among adolescents and young adults with cancer or a blood disorder: a discrete choice experiment. Health Policy. 2012:107, 304-311.
  • Cocks K, King MT, Velikova G, de Castro Jr G, Martyn St-James M, Fayers PM, Brown JM on behalf of the EBIG collaborative group. Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer quality of life questionnaire core 30 (EORTC QLQ-C30). European Journal of Cancer, 2012: 48(11), 1713-1721.
  • Blinman P, King M, Norman R, Viney R, Stockler MR. Patients’ preferences for cancer treatments: an overview of methods and applications in oncology. Annals of Oncology (IF 6.452). 2012: 23(5),1104-1110. doi:10.1093/annonc/mdr559.
  • Colagiuri B, King MT, Butow PN, McGrane JA, Luckett T, Price MA, Birney DP, Australian Ovarian Cancer Study Group - QoL Study Group. A comparison of the FACT-G and SCNS in women with ovarian cancer: Unidimensionality of Constructs. Australian Ovarian Cancer Study. QOL Research, 2012:21(5), 887-897. DOI 10.1007/s11136-011-9993-5
  • Kassab M, Sheehy A, King M, Fowler C, Foureur M. A Double-Blind randomised controlled trial of 25% oral glucose for pain relief in 2-month old infants undergoing immunisation. International Journal of Nursing Studies, 2012, 49 (3), 249-256.
  • McKinley S, Aitken L, Alison J, King M, Leslie – Curtin G, Burmeister E, Elliott D. Sleep and other factors associated with mental health and psychological distress after intensive care for critical illness. Intensive Care Medicine.2012: 38(4), 627-633. DOI 10.1007/s00134-012-2477-4.
  • King MT, Viney R, Smith DP, Hossain I, Street D, Savage E, Fowler S, Berry MP, Stockler M, Cozzi P, Stricker P, Ward J, Armstrong BK. Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer. British Journal of Cancer (IF 4.346,) 2012. 106, 638 – 645.
  • Jeon Y, Luscombe G, Chenoweth L, Stien-Parbury J, Brodaty H, King M, Haas M. Staff outcomes from the Caring for Aged Dementia Care REsident Study (CADRES): A cluster randomised trial. International Journal of Nursing Studies, 2012: 49 (5), 508-518.
  • Girgis A, Stojanovski E, Boyes A, King M, Lecathelinais C. The next generation of the Supportive Care Needs Survey: A brief Screening Tool for electronic administration in the clinical oncology setting. Psycho-Oncology. 2012: 21(8),827-835. DOI: 10.1002/pon.1973.
  • Butow PN, Lobb E, Jefford M, Goldstien D, Eisenbruch M, Girgis A, King M, Aldridge L, Schofield P. A bridge between cultures: interpreters’ perspectives of consultations with migrant oncology patients. Supportive Care in Cancer. 2012: 20 (2): 235-44.
  • Luckett T, Goldstein D, Butow P, Gebski V. Aldridge LJ, McGrane J, Ng W & King MT. The psychological wellbeing and quality of life of US Hispanic and Asian/Pacific Islander cancer patients compared to the majority: A systematic review and meta-analysis. Lancet Oncology (IF 17.764), 2011: 12 (13), 1240-1248.
  • Martinelli F, Quinten C, Maringwa JT, Coens C, Vercauteren J, Cleeland CS, Flechtner H, Gotay C, Greimel E, King M, Mendoza T, Osoba D, Reeve BB, Ringash J, Koch JS, Shi Q, Taphoorn MJ, Weis J, Bottomley A on behalf of the European Organisation for Research and Treatment of Cancer Clinical Groups. Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data. Expert Review in Pharmacoeconomics and Outcomes Research. 2011: 11(5):587-599. PMID:21958103.
  • Elliott D, McKinley S, Alison J, Aitken LM, King M, Leslie GD, Kenny P, Taylor P, Foley R, Burmeister B. Health-related quality of life and physical recovery after a critical illness: a multi-centre randomised controlled trial of a home-based physical rehabilitation program. Critical Care, 2011: 15 (3), art. no. R142.
  • Giesinger JM, Petersen MAA, Groenvold M, Aaronson NK, Arraras JI, Conroy T, Gamper EM, Kemmler G, King MT, Oberguggenberger AS, Velikova G, Young T, Holzner B and European Organisation for Research and Treatment of Cancer Quality Of Life Group (EORTC-QLG). Cross-cultural development of an item list for computer-adaptive testing of fatigue in oncological patients. Health and Quality of Life Outcomes, 2011: 9. Art no.19. DOI:10.1186/1477-7525-9-19.
  • Viney R, Norman R, King MT, Cronin P, Street DJ, Knox S, Ratcliffe J. Time Trade-Off Derived EQ-5D Weights for Australia. Value in Health, 2011: 14(6): 928-936.
  • King MT A point of minimal important difference (MID): A critique of terminology and methods. Expert Review of Pharmacoeconomics & Outcomes Research, 2011; 11 (2), 171-184.
  • Rowen D, Brazier J, Young T, Gaugris S, Craig BM, King MT, Velikova G. Deriving a preference-based measure for cancer using the EORTC QLQ-C30. Value in Health. 2011: 14 (5), 721-731.
  • Maringwa JT, Quinten C, King M, and the PROBE Research Team. Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Supportive Care in Cancer, 2011: 19 (11), 1753-1760.
  • Maringwa JT, Quinten C, King M, and the PROBE Research Team. Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Annals of Oncology (IF 5.647). 2011: 22(9), 2107-2112.
  • Luckett T, King MT, Butow PN, Oguchi M, Rankin N, Price MA, Hackl NA, Heading G Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. Annals of Oncology (IF 5.647). 2011: 22 (10): 2179-90.
  • Cocks K, King MT, Velikova G, Martyn-St James M, Payers PM, Brown JM, on behalf of the EBIG collaborative group. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer quality of life questionnaire core 30 (EORTC QLQ-C30). Journal of Clinical Oncology. 2011: 29 (1): 89-96.
  • Chenoweth L, King M, Luscombe G, Forbes I, Jeon YH, Parbury JS, Brodaty H, Fleming R, Haas M. Study protocol of a randomised controlled group trial of client and care outcomes in the residential dementia care setting. Worldviews on Evidence- Based Nursing. 2011: 8(3), 153-65.
  • Luckett, T., Butow, P.N., King, M.T., Oguchi, M., Heading, G., & Hackl, N.A., Rankin, N. and Price, M. (2010). A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses. Support Care Cancer, 18,1241–1262
  • Price MA, Butow PN, Costa DS, King MT, Aldridge LA, Fardell J, DeFazio A, Webb PM, Australian Ovarian Cancer Study Group, Australian Ovarian Cancer Study Quality of Life Investigators. Prevalence and predictors of anxiety and depression in women with invasive ovarian cancer and their carers. Med J Aust. 2010. 193(5): S52-S57.
  • Butow PN, Sze M, Dugal-Beri P, Mikhail M, Eisenbruch M, Jefford M, Schofield P, Girgis A, King MT, Goldstein  D, on behalf of the Psycho-Oncology Co-operative Research Group (PoCoG).  From inside the bubble: Migrants perspective on coping with cancer in a foreign health system. Supportive Care in Cancer (IF .279). 2010, 19(2),281 – 290.
  • King MT , Stockler MS, Cella D, Osoba D, Eton D, Thompson J, Eisenstein A. Meta-analysis provides evidence-based effect sizes for a cancer-specific quality of life questionnaire, the FACT-G. Journal of Clinical Epidemiology 2010, 63 (3), pp. 270-281. (IF 2.57).
  • Smith DP, King MT, Egger S, Berry M, Stricker P, Cozzi P, Ward J, O’Connell DL, Armstrong BK. Quality of life three years after treatment for localised prostate cancer: A population-based study. British Medical Journal, 2010: 340 (7739), pp. 195.
  • Butow P, Palmer S, Pai A, Goodenough B, Luckett, T, King, MT. A review of adherence-related issues in adolescents and young adults with cancer. JCO. 2010, 28 (32), pp. 4800 – 4809.
  • Norman R, Cronin P, Viney R, King MT, Street D, Brazier J, Ratcliffe J. International Comparisons in Valuing EQ-5D Health States: A Review And Analysis. Value in Health,  2009, 19, pp. 499-508. (IF=3.387).
  • Duffield, C., Diers, D., O'Brien-Pallas, L, Aisbett, C., Roche, M.r, King, M., Aisbett, K. Nursing staffing, nursing workload, the work environment and patient outcomes. Applied Nursing Research (IF 4.443) 2011: 24 (4), 244-255
  • Fayers, P.M., King, M.T. How to guarantee finding a statistically significant difference: The use and abuse of subgroup analyses. Quality of Life Research:2009, 18 (5), pp. 527-530 (IF= 2.985)
  • Fayers PM, King MT. In reply to Berger "don't test for baseline imbalances unless they are known to be present?" Quality of Life Research 2009, 18 (4), pp. 401-402. (IF=2.169)
  • Luckett T, King MT, Butow P, Friedlander M, Paris T. Assessing Health-related Quality of Life in Gynecological Oncology: A Systematic Review of Questionnaires and their Ability to Detect Clinically Important Differences and Change. International Journal of Gynecological Cancer, 2010, 20 (4), pp. 664-684.
  • Knox S, King MT. Validation and calibration of the SF-36 health transition question against an external criterion of clinical change in health status. Quality of Life Research 2009, 18 (5), 637-645.(IF = 2.47).
  • Chenoweth L, King MT, Jeon Y, Brodaty H, Stein-Parbury J, Norman R, Haas M, Luscombe G. Caring for Aged Dementia Care REsident Study (CADRES), a cluster-randomised trial of Person-Centred-Care, Dementia Care Mapping and Usual Care in dementia. Lancet-Neurology 2009, 8 (4), 317-325 (IF 10.2).
  • Kenny P, Hall JP, King MT, Lancsar E. Sources of variation in the costs of health care for asthma patients in Australia. Journal of Health Services Research & Policy 2009, 14 (3), 133-140 (IF 2.55).
  • King MT, Kenny PM, Marks GB. Measures of asthma control and quality of life: Longitudinal data provide practical insights into their relative usefulness in different research contexts. Quality of Life Research 2009, 18 (3), pp. 301-312 (IF 2.47) .
  • Luckett T, Butow P, King MT . Improving Outcomes through the Routine Use of Patient Reported Data in Cancer Clinics: A Critical Review . Psycho-Oncology (IF 2.59); in press (accepted 5/1/09). Published online 24/03/09. DOI: 10.1002/pon.1545
  • Bottomley A, Quinten C, Coens C, Martinelli F, Mauer M, Maringwa J, Cleeland CS, Flechtner H, Gotay C, Greimel E, King MT , Taphoorn M, Reeve BB, Ringash J, Schmucker-Von Koch J. Making better use of existing cancer data: Patient Reported Outcomes and Behavioural Evidence (PROBE): A new international initiative (Editorial). European Journal of Cancer Care 2009; 19: 105-7. (IF 0.09)
  • Ewing J, King MT, Smith N. Validation of modified forms of the PedsQL generic core scales and cancer module scales for adolescents and young adults (AYA) with cancer or a blood disorder. Quality of Life Research 2009; 18(1): 231–244. DOI 10.1007/s11136-008-9424-4 . (IF 2.47)
  • Fayers P, King MT . A highly significant difference in baseline characteristics: the play of chance or evidence of a more selective game? Quality of Life Research 2008 , 17 (9), 1121-1123 (IF 2.47)
  • Fayers P, King MT . The baseline characteristics did not differ significantly. Quality of Life Research 2008: 17(8); 1047-8. (IF 2.47)
  • Cocks K, King MT, Velikova G, Fayers P, Brown J. Quality, interpretation and presentation of EORTC QLQ-C30 data in randomised controlled trials European Journal of Cancer. European Journal of Cancer 2008: 44(13); 1793-8. (IF=1.63)
  • Luckett T, Butow PN, King MT, Olver IN. Psychosocial issues in long-term survivors of testicular cancer. Asia Pacific Journal of Clinical Oncology 2008; 4(3): 125-31 .
  • O’Connor DW, Ames D, Gardner B, King MT. Psychosocial treatments of behavior symptoms in dementia: a systematic review of reports meeting quality standards. International Psychogeriatrics 2009: 21(2) 225-240
  • O’Connor DW, Ames D, Gardner B, King MT. Psychosocial treatments of psychological symptoms in dementia: a systematic review of reports meeting quality standards. International Psychogeriatrics 2009: 21(2) 241-251
  • Lee BB, Simpson JM, King MT, Haran MJ, Marial O. The SF-36ww (walk-wheel): A simple modification of the SF-36 physical domain improves its responsiveness for measuring health status change in Spinal Cord Injury. S pinal Cord, 2009, 47, 50-55 ( advance online publication 17/6/08; doi: 10.1038/sc.2008.65) (IF=1.59)
  • Kenny PM, King MT, Viney RC, Boyer MJ, Pollicino CA, McLean JM, Fulham MJ, McCaughan BC. Quality of life and survival in the two years after surgery for non-small cell lung cancer . Journal of Clinical Oncology ( IF=13.6 ), 2008; 26(2): 233-241 .
  • Lee B, King M, Haran M, Marial O, Simpson J, Salkeld J. Validity and Minimal Important Difference for the SF-6D Health Rating Scale in a Spinal Cord Injured population. Value in Health (IF=3.4) 2008; 11(4): 680-688.
  • Smith DP, Supramaniam R, King MT, Ward J, Berry M, Armstrong BK. Age, health and education determine supportive care needs of younger men with prostate cancer. of Clinical Oncology ( IF=13.6) 2007; 25(18): 2560 - 2566.
  • King MT , Hall J, Lancsar E, Fiebig DG, Hossain I, Louviere JJ, Reddel H, Jenkins, C. Patient preferences for managing asthma: Results from a discrete choice experiment. Health Economics (IF=2.0) , 2007; 16(7): 703-717.
  • Lanscar EJ, Hall JP, King MT, Kenny PM, Louviere JJ, Fiebig DG, Hossain I, Thien FCK, Reddel HK, Jenkins, CR. Using discrete choice experiments to investigate subject preferences for preventive asthma medication. Respirology (IF=1.5) 2007; 12(1): 127-136.
  • Elliott D, McKinley S, Alison J A, Aitken LA, King M. Study protocol: Home-based physical rehabilitation for survivors of a critical illness, Critical Care (IF=3.1) 2006; 10, R90.
  • Hall J, Fiebig DG, King MT, Hossain I, Louviere JJ. What influences participation in genetic carrier testing? Results from a discrete choice experiment. Journal of Health Economics (IF=2.0), 2006; 25; 520-537.
  • Kovoor P, Lee AKY, Carrozzi F, Wiseman VL, Byth K, Zecchin RP, Dickson C, King MT, Hall JP, Ross DL, Uther JB, Denniss AR. Economic evaluation of a randomised trial of early return to normal activities versus cardiac rehabilitation after acute myocardial infarction. American Journal of Cardiology (IF= 3.0), 2006; 97(7): 952-958.
  • Haran MJ, Lee BB, King MT, Marial O, Stockler MR. Health status rated with the Short-Form 36 (SF-36) Health Survey after spinal cord injury. Archives of Physical Medicine and Rehabilitation (IF=1.8), 2005; 86(12); 2290-2295.
  • Kenny P , Lancsar E, Hall JP, King MT, Chaplin M. The individual and health sector costs of asthma: the first year of a longitudinal study in New South Wales Australian and New Zealand Journal of Public Health (IF=1.1), 2005; 29(5): 429-435.
  • Viney RC, Boyer MJ, King MT, Kenny PM, Pollicino CA, McLean JM, McCaughan BC, Fulham MJ. A randomised controlled trial of the role of positron emission tomography in the management of Stage I and II non-small cell lung cancer. Journal of Clinical Oncology (IF=13.6), 2004; 22(12): 2357-2362. TTU (cited by 55)
  • Viney R.C., Boyer M.J., King M.T., Spigel D.R. Staging lung cancer using positron emission tomography and the impact on care.Journal of Clinical Outcomes Management, 2004 (IF not listed); 11(8): 486-488.
  • Bridges JFP, Stewart M, King MT, van Gool K. Adapting portfolio theory for investment in health, with a multiplicative extension for treatment synergies. HEPAC: the European Journal of Health Economics (IF not listed), 2002; 3(1): 47-53.
  • Hall JP, Wiseman VL, King MT, Ross DL, Kovoor P, Zecchin RP, Moir FM, Denniss AR. Economic evaluation of a randomised trial of early return to normal activities versus cardiac rehabilitation after acute myocardial infarction. Heart, Lung and Circulation (IF not listed), 2002; 11(1): 10-18.
  • Hall JP, Kenny P, King MT, Louviere JJ, Viney R,Yeoh A. Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination. Health Economics (IF=2.0), 2002; 11(5): 457-465.
  • King MT , Kenny P, Shiell A, Hall JP, Boyages J. Quality of life three months and one year after treatment for early stage breast cancer: influence of treatment and patient characteristics. Quality of Life Research (IF=2.0) 2000; 9(7): 789-800.
  • Brown JE, King MT, Butow PN, Dunn SM, Coates AS. Patterns over time in quality of life, coping and psychological adjustment in late stage melanoma patients: an application of multilevel models. Quality of Life Research (IF=2.0) 2000; 9(1): 75-85.
  • King MT , Dobson AJ. Estimating the responsiveness of an instrument using more than two repeated measures. Biometrics (IF not listed) 2000; 56 (December): 1197-1203
  • King MT , Hall J, Caleo S, Gurney H, Harnett P. Home or Hospital? An evaluation of the costs, preferences and outcomes of domiciliary chemotherapy. International Journal of Health Services (IF not listed) 2000; 30(3): 557-579.
  • Brown JE, Brown RF, Miller RM, Dunn SM, King MT, Coates AS, Butow PN. Coping with metastatic melanoma: the last year of life. Psycho-Oncology (IF=2.8) 2000; 9(4): 283-292.
  • Brown JE , Brown RF , Miller RM , Dunn SM , King MT , Coates AS , Butow PN. Testing health care professionals' communication skills: The usefulness of highly emotional standardized role-playing sessions with simulators. Psycho-Oncology 2000; 9(4), pp. 293-302(IF=2.8).
  • Klee MC, King MT, Machin D, Hansen HH. A Clinical Model for Quality of Life Assessment in Cancer Patients Receiving Chemotherapy. Annals of Oncology (IF=5.2) 2000; 11(1): 23-30
  • Kenny P, King MT, Shiell A, Seymour J, Hall J, Langlands A, Boyages J. Early stage breast cancer: costs and quality of life one year after treatment by mastectomy or conservative surgery and radiation therapy. The Breast (IF=1.7) 2000; 9: 37-44.
  • Warner N, King MT, Langlands, A, Kenny P, Boyages, J. Symptoms 2 weeks, 3 months and 12 months after treatment of early stage breast cancer: the patient ’ s perspective. The Breast (IF=1.7) 1999; 8: 273-277.
  • King MT. The interpretation of scores from the quality of life questionnaire QLQ-C30 Quality of Life Research (IF=2.3) 1996; 5(6): 555-567.
  • King MT , Dobson AJ, Harnett PH. A comparison of two quality-of-life questionnaires for cancer clinical trials: the Functional Living Index - Cancer (FLIC) and the Quality of Life Questionnaire Core module (QLQ-C30) J Clin Epi 1996; 49(1):21-29. (IF=2.57)
  • Scott A, Shiell A, King MT. Is general practitioner decision-making associated with socio-economic status? Soc Sci Med 1996; 42(1):35-46. (IF not listed)
  • Olson LG, King MT, Saunders NA, Hensley MJ. Emerging issues in sleep‑disordered breathing. Medical Journal of Australia 1996;165(2):107‑10.(IF=2.54)
  • Olson LG, King MT, Hensley MJ, Saunders NA. A community study of snoring and sleep-disordered breathing. I: Prevalence and risk factors. Am J Respir Crit Care Med 1995; 152(2): 711‑716. (IF=1.08)
  • Olson LG, King MT, Hensley MJ, Saunders NA. A community study of snoring and sleep-disordered breathing. II: Health outcomes. Am J Respir Crit Care Med 1995; 152(2): 717‑720. (IF=1.08)
  • Olson LG, King MT, Hensley MJ, Saunders NA. A community study of snoring and sleep-disordered breathing. III: Symptoms. Am J Respir Crit Care Med 1995; 152(2): 707‑710. (IF=1.08)
  • Mant A, King MT, Saunders NA, Pond DC, Goode E, Hewitt H. Four-year follow-up of mortality and sleep-related respiratory disturbance in non-demented seniors Sleep 1995; 18(6): 433-438 (IF=4.34)
  • Chapman S, King MT, Andrews B, McKay E, Markham P, Woodward S. Publicity and warning letter affecting cigarette sales to minors. Aust J Public Health 1994; 18:39-42 (IF not listed)
  • Dorsch NWC, King MT. A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage I: Incidence and effects. J Clin Neuroscience 1994; 1:19-26. (IF=0.80)
  • Kenny P, King MT, Cameron S, Shiell A. Satisfaction with postnatal care - the choice of home or hospital. Midwifery 1993; 9:146-153. (IF=0.85)
  • Shiell A, Cameron S, Kenny P, King MT. Mother's choice: reasons women choose hospital stay over early discharge. Health and Social Care 1993; 2: 69-76.
  • Guylay S, Olson LG, Hensley MJ, King MT, Muree-Allen K and Saunders NA. A comparison of clinical assessment and home oximetry in the diagnosis of obstructive sleep apnoea Am Rev Resp Dis 1993; 147(1):50-53.
  • Chapman S, Marks R and King MT. Trends in tans and skin protection in Australian fashion magazines, 1982 through 1991. Am J Public Health 1992; 82(12):1677-1680.
  • Lord S, O'Connell D, King MT, et al. Night-to-night variability of disturbed breathing during sleep in an elderly community sample. Sleep 1991; 14(3): 252-258.
  • King MT , White T, Guylay S et al. A portable system for home monitoring of sleep apnoea. J Ambulatory Monitoring 1991; 4:113-122.

COMMENTS & LETTERS

  • King MT, Fayers PM. Making quality of life results more meaningful for clinicians [invited comment]. Lancet 2008; 371: 709-710 (IF=25.8) (cited by 1)
  • Fulham MJ, McCaughan BC, Boyer MJ, McLean JM, Kenny PM, King MT, Pollicino CA, Viney RC. FDG-PET in Stage I/II NSCLC: the Australian RCT [letter]. Journal of Clinical Oncology 2005; 23: 591-1592.
  • White L, Ewing J, Senner AM, King MT, Goodenough B. Cancer in adolescents and young adults [letter]. Medical Journal of Australia 2004; 181: 338 .
  • King MT, Street D, Burgess L, Louviere JJ. Readers need more information on Discrete Choice Experiments. British Medical Journal Rapid response. http://bmj.bmjjournals.com/cgi/eletters/328/7436/382#51656 (accessed 19 January 2005).
  • Viney RC, King MT, Savage EJ, Hall JP. Use of the “transfer to utility” (TTU) is questionable [letter in Matters Arising]. Medical Journal of Australia 2004; 181 (6): 338.
  • King MT , Hall JP. Harnett PR. A randomised crossover trial of chemotherapy in the home: patient preferences and cost analysis [letter]. Medical Journal of Australia 2001; 174(6):312.

BOOK REVIEWS & MEETING REPORTS
  • King MT . Book review: Measuring Quality of Life in Health by Rod O’Connor, Elsevier/ Churchill Livingstone, London, 2004. Quality of Life Research (2007) 16:1093–1094 .
  • King MT . Harmonizing International Health-Related Quality of Life (HRQOL) Research: ISOQOL’s 11 th Annual Scientific Meeting. 16-19 th October 2004, Hong Kong, China. [ Meeting report ] . Expert Review of Pharmacoeconomics & Outcomes Research 2005; 5(1): 9-10.
  • King MT . 10 th Annual Australian Health Outcomes Conference 2004: 10 years on and going strong. [ Meeting report ] . Expert Review of Pharmacoeconomics & Outcomes Research 2004; 4(6): 613-615.
  • King MT and Stewart MI. Book review: Design and Analysis of Quality of Life Studies in Clinical Trials by Diane L Fairclough, Chapman & Hall/CRC Press, Boca Raton, 2002. Quality of Life Research 2004 ; 13(1): 275-277.
  • King MT . Book review: Adaptation to Changing Health: Response Shift in Quality of Life Research by Carolyn E Schwartz and Mirjam A.G. Sprangers, American Psychological Association, Washington, DC, 2000. Quality of Life Research 2002 ; 11(2): 185-187.
  • King MT . Book review: Measuring Health: a Review of Quality of Life Measurement Scales by Ann Bowling, 2nd Ed, 1997, Open University Press, Buckingham . Australian Health Review 1998; 21(4): 271-273.

OTHER RESEARCH PAPERS & REPORTS
  • Kenny P, Hall J, King M. Variation in the costs of healthcare for chronic disease in Australia: The case of asthma. CHERE Working Paper 2008/7, Centre for Health Economics Research and Evaluation, Sydney, 2008.
  • Norman R, Haas M, Chenoweth L, Jeon Y-H, King MT, Brodaty H, Stein-Parbury J, Luscombe G. Dementia care mapping and patient-centred care in Australian residential homes: An economic evaluation of the care study. CHERE Working Paper Series. Sydney: Centre for Health Economics Research and Evaluation. 2008
  • Norman R, Cronin P, Viney R , King MT, Street D, Brazier J, Ratcliffe J. Valuing EQ-5D Health States: A Review And Analysis. CHERE working paper 2007/9 , CHERE, Sydney, 2007. http://www.chere.uts.edu.au/pdf/wp2007_9.pdf
  • Knox S, King MT. Validation and calibration of the SF-36 health transition question in the Household, Income and Labour Dynamics in Australia (HILDA) survey . CHERE Working Paper 2007/15, CHERE, Sydney, 2007. http://www.chere.uts.edu.au/pdf/wp2007_15.pdf
  • King MT , Winstanley J, Kenny P, Viney R, Zapart S, Boyer M. Validity, reliability and responsiveness of the EORTC QLQ-C30 and the EORTC QLQ-LC13 in Australians with early stage non-small cell lung cancer. CHERE Working Paper 2007/13 , CHERE, Sydney, 2007. http://www.chere.uts.edu.au/pdf/wp2007_13.pdf
  • Duffield C, Roche M, O’Brien-Pallas L, Diers D, Aisbett C, Hall J, King M.Glueing it together: Nurses, their work environment and patient safety . Final Report, Centre for Health Services Management, University of Technology, Sydney. Retrieved Nov 7 2007 from the NSW Department of Health website: http://www.health.nsw.gov.au/pubs/2007/nwr_report.html
  • Haran MJ, King MT, Stockler MR , Marial O, Lee BB . Validity of the SF-36 Health Survey as an outcome measure for trials in people with spinal injury. CHERE Working Paper 2007/4, CHERE, Sydney, 2007. http://www.chere.uts.edu.au/pdf/wp2007_4.pdf
  • Sansoni J, Marosszeky N, Jeon Y, Chenoweth L, King M, Hawthorne G, Zapart S, Sansoni E. Second Report: Dementia Outcomes Measurement Suite Project. Centre for Health Service Development, University of Wollongong, Jan 2007.
  • King M, Viney R, Hossain I, Smith D, Fowler S, Savage E, Armstrong B. Men’s preferences for treatment of early stage prostate cancer: Results from a discrete choice experiment, CHERE Working Paper 2006/14, CHERE, Sydney, 2006. http://www.chere.uts.edu.au/pdf/wp2006_14.pdf
  • Australian Centre for Asthma Monitoring. Measuring the impact of asthma on quality of life in the Australian Population. AIHW cat. No. ACM 3 Canberra 2004. ( King MT was one of 5 people who prepared this report on behalf of ACAM)
  • Kenny P, Mahmic A., Lancsar E, Anderson R, King M, and Hall J. Diaries or questionnaires for collecting self-reported healthcare utilisation and patient cost data? CHERE Project Report No 20, CHERE, 2003. http://www.chere.uts.edu.au/pdf/rep20.pdf
  • Kenny P, King MT, Shiell A, Seymour J, Boyages J, Hall J. Quality of life three months and one year after treatment for early stage breast cancer. CHERE Discussion Paper Series No.42, 2000.
  • Kenny P, Viney R, Gerard K, Hall J, King M, Shanahan M. Managing breast cancer: what does economics have to offer? Health Economics Review, 14; December 1999.
  • Caleo S, King MT, Cameron SP, Hall JA. Evaluation of Domiciliary Chemotherapy. Report to the Cancer Council of Australia, CHERE, 1996.
  • Scott A, King MT, Shiell A. Factors influencing decision making in general practice: the feasibility of analysing secondary data. CHERE Discussion Paper Series No.16, 1993.
  • Scott A, Cameron S, Kenny P, King MT, Shiell A. Evaluation of obstetric early discharge: economic evaluation. CHERE Discussion Paper Series No. 12, 1992.
  • Cameron S, Kenny P, Scott, King MT. Evaluation of obstetric early discharge: reasons for non-participation. CHERE Discussion Paper Series No. 11, 1992.
  • Kenny P, Cameron S, King MT, Scott A, Shiell A. Evaluation of obstetric early discharge: client satisfaction. CHERE Discussion Paper Series No. 10, 1992.
  • Cleland S, Cameron S, Kenny P, King MT, Scott A, Shiell A. Evaluation of obstetric early discharge: an overview. CHERE Discussion Paper Series No 9, 1992.
  • Shiell A, Haas M, King MT, Jan S, Seymour J. Optimal size and throughput of tertiary services: a case study of renal transplant and cardiac surgery in NSW. CHERE Discussion Paper Series No 5, 1992.
  • Cameron S, Kenny P, Scott A, King MT. Reasons for non-participation in an obstetric early discharge program. Report to the Westmead Research Institute 1992.
  • Scott A, Kenny P, Cameron S, King MT. An economic evaluation of obstetric early discharge. Report to Western Sydney Area Health Service 1991.
  • King MT . Prevalence, risk factors and diagnostic predictors of disordered breathing during sleep in snorers (Internal report) Newcastle, NSW: University of Newcastle, 1991.
Back to Table of Contents

Research Grants and Awards

GRANTS

PEER-REVIEWED EXTERNAL GRANTS  
# Source Investigators Title Years Amount
GR30 National Institute for Health Research - School for Primary Care Research (NSPCR) Calvert, Kyte, Draper, Ives, Gheorghe, Brundage, King, Mercieca-Bebber, Blazeby Evaluation of patient reported outcomes in clinical trials: systematic review of trial protocols  2013 £23,976
(valued at $35,900 AUD 23/01/2013)
GR29 CA
APP1046923 		Morton, Forgarty, Nowak, King (5%), Hong Economic evaluation of whole brain radiotherapy in melanoma  2013 – 2015 $184,475
GR28 CA & PdCCRS partners
APP1041733		 Grimison, Toner, Stockler, Friedlander, Thompson, Gebski, Singhal, King (5%), Boland Acceleration first line chemotherapy for advanced germ cell tumours  2013 – 2015 $598,001.08
GR27 App1047673
NHMRC		 Rischin, Corry, Fisher, King (5%), Porceddu A randomized trial of radiation with cetuximab or weekly cisplatin in low risk locoregionally advanced HPV-associated oropharyngeal cancer  2013-2017 $1,097,932.46
GR26 App1030265
Cancer Australia 		Lehman, Michael, King (5%), Ball, Burmeister, Fisher A randomised phase III comparison of palliative radiotherapy versus combined chemotherapy and palliate radiotherapy in good performance status patients with stage III/IV NSCLC not suitable for radical therapy  2012 – 2014 $280,000
GR25 EORTC Winstanley, King (5%), Thompson, Kefford, White, Myles, Paton, van de Poll-Franse, Bergenmar, Koller, Constantini, Garioch, Steinbauer Development of an EORTC Quality of Life Module specific to Melanoma (EORTC QLQ – MEL)
Phases 1 – 3		 2011 - 2012 $134,570.00 – based on exchange rate 01/07/11
(€99,991)
GR24 10/RFG/2-66
CINSW Research Innovation Grant		 Milross & King (5%) Development of a questionnaire to measure patients' & doctors' perceptions of the inconvenience associated with radiotherapy  2011 $49,913
GR23 NHMRC
APP1001214 		Emery, Schofield, Jefford, King (5%), Piroota, Hayne, Martin, Trevena A phase II trial of prostate cancer follow-up in primary care  2011-2013 $564,410
GE22 CI NSW 09/RFG/2-38 King, Freidlander PROMIS: a new paradigm for quality of life assessment - a NSW-based proof-of-concept study.  2010 $50,000
GE21 NHMRC 2009 632662 King M, Viney R, Pallant J, Janda M, Grimison P. Development and valuation of cancer-specific multi-attribute health states for use in economic evaluation. 2010 - 2012 $679,950

GE20

NSW CI Research Infrastructure Grant 09/RIG/1-13

Butow, King, Girgis, Meiser, Vardy, White, Rankin, Price

The Psycho-oncology Co-operative Research Group: infrastructure to

support operational activity and facility management to further psychosocial

research and quality of life studies in clinical trials.

2010-2012

$330,000

GE19

NSW Cancer Institute Innovation Grant

King , Barton, Ng, Viney, Grimison

Development of cancer-specific multi-attribute health states from the QLQ-C30 for use in economic evaluation

2009

$47,814

GE18

Cancer Australia: Boost Cancer Research

Emery, Gunn, Pirotta, Trevena, Barratt, McCaffery, Mitchell, Kilbreath, Monterosso, Foreman, Booth, Weller, Forster, King.

Establishment of a multi-site, collaborative national clinical trials group: Primary Care Co-operative Clinical Trials Group

2009

$219,564

GE17

Ca Aust / Cancer Council

Young, Solomon, Frizelle, Heriot, King, Salkeld.

Quality of life outcomes and cost effectiveness of pelvic exenteration for people with advanced rectal cancer.

2009

$102,850

2010

$102,850

2011

$179,350

GE16

NHRMC Project grant

570893

Friedlander , King, Gainford, Oza.

Does Palliative Chemotherapy Improve Symptoms in Women with Recurrent Ovarian Cancer?

2009

$178,700

2010

$173,700

2011

$149,850

GE15

Cancer Australia

Olver, Butow, Luckett, Grimison, Toner, King.

Understanding the psychosocial sequelae of surviving testicular cancer.

2009

$118,350

2010

$98,350

GE14

Beyondblue& Cancer Australia

Butow, Goldstein, Eisenbruch, Jefford, King, Girgis.

Psychological morbidity, unmet needs, quality of life and patterns of care in migrant cancer patients: the first year.

2009

$200,000

2010

$200,000

2011

$200,000

GE13

Dementia Research Grant 513103

Chenoweth, Forbes, King, Stein-Parbury, Haas, Jeon, Fleming, Brodaty.

Person-centred environment and care for residents with dementia: a cost-effective way of improving quality of life and quality of care?

2008-2010

$345,780 $769,988 $357,627 $1,473,725

GE12

NHMRC Project Grant 457432

Butow, Girgis, Goldstein, Eisenbruch, Schofield, Jefford, King.

Psychological morbidity, unmet needs and patterns of care in culturally and linguistically diverse cancer patients in Aust.

2007

2008

$203,878 $198,878 $401,756

GE11

NHMRC Project Grant 387700

Armstrong, Smith, Berry, King, Stricker, Rogers.

Five year outcomes of care for prostate cancer in New South Wales

2006

2007

2008

$127,993 $99,862 $66,249 $300,476

GE10

NHMRC Project Grant 403303

Viney, Brazier, Street, King, Ratcliffe.

Discrete choice experiments to value multi-attribute health states for use in economic evaluation

2006

2007

2008

$165,750 $214,250 $53,750 $440,625

GE9

AHMAC

Chenoweth, Brodaty, King, Jeon, Stein-Parbury.

Measuring the efficacy of Dementia Care Mapping in residential aged care.

2005-

2007

$199,870

GE8

Cancer Institute NSW Research Infra-structure Grant

Butow, Dunn, Girgis, Kelly, King, Mason, Meiser, Solomon, Stockler, Tattersall, White.

NSW Psycho-oncology Cooperative Research Group (PoCoG)

2005–2007

$179,000

GE7

Cancer Research UK

Brown, King, Fayers, Hawkins.

Evidence-based interpretation guidelines for quality of life measures

2005-2007

$416,142

GE6

NHMRC Project

Grant 352407

Elliott, McKinley, Alison, Aitken, King.

Testing a home based rehab program for survivors of a critical illness - RCT

2005-2007

$140,300

$130,300

$62,650

$338,875

GE5

ARC Discovery

Devinney, Louviere, Auger, Gunnthors-dottir, King.

Information provision and the valuation of social issues

2005-2007

$205,000

GE4

DVA Project Grant NHMRC 240400

Armstrong, Smith, Rogers, Berry, Ward, King.

Care and outcomes of care for prostate cancer in New South Wales

2003-2005

$577,750

GE3

NHMRC Project Grant 9937980

Viney, Fulham, King, Boyer, McCaughan.

RCT: Economic evaluation of Positron Emission Tomography in the management of Non Small Cell Lung Cancer

1999-2001

$289,950

GE2

NHMRC Project Grant 9937376

Hall, King, Viney.

Economic evaluation of genetic screening for Tay Sachs disease and Cystic Fibrosis using discrete choice modelling

1999-2001

$211,450

GE1

NSW Cancer Council Project Grant

Gurney, Harnett, Hall, King M.

Evaluation of domiciliary chemotherapy

1992-1994

$57,000

PEER-REVIEWED INTERNAL GRANTS TOTAL:

GI6

University of Sydney ‘Near Miss’ Grant

Winstanley on behalf of ANZMTG, King

Improving Quality of Life measurement for melanoma patients: Validity and reliability study of QoL instruments in a NSW population

2009

$40,000

GI5

Dementia Collaborative Research Centre Project

O’Connor, Runci, Ames, Camp, Fleming, King, Luszcz.

Volunteer-facilitated, personalised, one-to-one interaction using Montessori-type activities as a treatment of challenging behaviours in people with dementia from culturally and linguistically diverse backgrounds: a pilot controlled trial.

2008

$30,000

GI4

UTS Faculty of Business Research Grant

King , Viney, Brazier, Pickard, Aaronson, Peacock.

Including quality of life in cancer funding policy decisions: development of a utility measure from the QLQ-C30

2008

$10,000

GI3

UTS Early Career Research Grants Scheme

King , Stockler, Fayers.

Evidence-based guidelines for interpreting quality of life measures: a novel method illustrated with QLQ-C30

2003-2004

$18,000

GI2

UTS Incentive Grant Scheme

Viney, King, Louviere.

Using stated preference discrete choice modeling to value multi-attribute health states

2003-2004

$24,400

GI1

University of Sydney Medical Foundation Fellowship

Hall, Viney, Haas, King.

Development of a conceptual framework to identify the benefits of public

health programs and of methods for their valuation in economic evaluation

1998-2002

$825,000

GOVERNMENT & INDUSTRY CONSULTANCIES & CONTRACTS
 
2011 - 2013
Cancer Australia QOL Chair
Tender		 King Cancer Australia Chairin Cancer
Quality of Life Tender: PoCoG
Quality of Life Office		 $592,576.17
2009
CI NSW Measures of Psych Distress		 Butow, King, Rankin, Price, Luckett, Oguchi Literature review of psychosocial outcome measures - PoCoG- Consultancy Measures Review $19,790
2006 -2007
Dept Health & Aging contract

Sansoni, Budge, Hawthorne, King (5%), Marosszeky.

Dementia Outcomes Measurement Suite

$302,894
2003-2005
NSW Department of Health (tender)

Duffield, O’Brien-Pallas, Diers, Aisbett, Hall, King (5%).

Nursing workload, skill mix and models of care research in NSW

$1,156,500

OTHER GRANTS
 
OG4 2011 – 2012
Calvary Mater Research Grant 		Carter, Ang, Britton, Clover, Gianacas, King, Lambert Calibrating commonly used questionnaires for depression and anxiety in oncology to enhance comparability and communication of outcomes $17,367
OG3 2009-2010
ANZBCTG Discretionary Funding 		King (5%),
Butow P.		 Patient preferences substudy: Adjuvant Lapatinib and/or Trastuzumab Treatment Optimisation – PANZALTTO. $16,500

OG2

2009
auDA

King (5%), Butow, Price, Luckett.

Equipping the research community to assess quality of life in cancer

$19,790

OG1

2002-2003 AstraZeneca Educational Grant

King (20%), Eton, Cella.

Developing evidence-based interpretation guidelines for the FACT-G, a cancer-specific quality of life instrument

$60,000


Back to Table of Contents